Chione Ltd's Form 4 filing
Acrivon Therapeutics, Inc. (ACRV) · filed Jun 14, 2023
- Accession no.
- 0001213900-23-049014
- Filed
- Jun 14, 2023, 6:33 PM ET
- Trade date
- Jun 12-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $72.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chione LtdCIK 0001590232 | 10% Owner |
| Hadjimichael AndreasCIK 0001591256 | 10% Owner |
| Smolokowski WiaczeslawCIK 0001591274 | 10% Owner |
| Czernik MarcinCIK 0001591275 | 10% Owner |
| Nikolaou AnastasisCIK 0001954186 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2023 | Common Stock | SSaleDisposed | −2,000 | $12.34 | −$24,680 | 3,854,597 | Direct | |
| Jun 13, 2023 | Common Stock | SSaleDisposed | −3,000 | $12.30 | −$36,900 | 3,851,597 | Direct | |
| Jun 14, 2023 | Common Stock | SSaleDisposed | −893 | $12.13 | −$10,832.09 | 3,850,704 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.